Geneos Wealth Management’s Balchem Corp BCPC Stock Holding History

Geneos Wealth Management’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-111	Closed	-$11K	–	2627
2019 Q4	$11K	Buy	111 +60	+118%	+$6.05K	﹤0.01%	1944
2019 Q3	$5K	Hold	51	–	–	﹤0.01%	2124
2019 Q2	$5K	Hold	51	–	–	﹤0.01%	2138
2019 Q1	$4K	Hold	51	–	–	﹤0.01%	2121
2018 Q4	$4K	Hold	51	–	–	﹤0.01%	2081
2018 Q3	$5K	Hold	51	–	–	﹤0.01%	2080
2018 Q2	$5K	Hold	51	–	–	﹤0.01%	1938
2018 Q1	$4K	Hold	51	–	–	﹤0.01%	1921
2017 Q4	$4K	Hold	51	–	–	﹤0.01%	1900
2017 Q3	$4K	Hold	51	–	–	﹤0.01%	1851
2017 Q2	$3K	Hold	51	–	–	﹤0.01%	1878
2017 Q1	$4K	Sell	51 -26	-34%	-$2.19K	﹤0.01%	1766
2016 Q4	$6K	Hold	77	–	–	﹤0.01%	1605
2016 Q3	$5K	Buy	77 +51	+196%	+$3.39K	﹤0.01%	1599
2016 Q2	$1K	Sell	26 -575	-96%	-$35.2K	﹤0.01%	1781
2016 Q1	$37K	Buy	+601	New	+$36.1K	0.01%	897

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Geneos Wealth Management's BCPC Position: Q1 2020 in Review

Geneos Wealth Management sold out of Balchem Corp (BCPC) in Q1 2020, closing a stake of 111 shares — an estimated $11K sold.

Geneos Wealth Management first reported a position in BCPC in Q1 2016 and held it in 16 quarters. The position peaked at $37K in Q1 2016. 233 funds tracked by Wall St. Rank hold BCPC as of Q1 2020.

Geneos Wealth Management reported no remaining Balchem Corp position as of Q1 2020 after selling out during the quarter.
Geneos Wealth Management sold 111 Balchem Corp shares in Q1 2020, an estimated $11K.
Geneos Wealth Management first reported a position in Balchem Corp in Q1 2016 and held it in 16 quarters.
Geneos Wealth Management's Balchem Corp position peaked at $37K in Q1 2016.
233 funds tracked by Wall St. Rank held Balchem Corp as of Q1 2020.

Based on Geneos Wealth Management's 13F filing for Q1 2020, filed 7 Sep 2021.